MAXOCAINE Topical Anesthetic Anorectal

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: MAXOCAINE Topical Anesthetic Anorectal
Generic name: LIDOCAINE
Manufacturer: PRIME COMMERCE, LLC
Product type: HUMAN OTC DRUG
SPL set ID: 26e8c867-8cb8-4a25-91b1-da45a1edd09a
SPL ID: 361dcf5a-5697-6935-e063-6294a90aaee1
Version: 4
Effective date: 2025-05-27
Source export date: 2026-10-27
Source partition: 9
Source file: https://download.open.fda.gov/drug/label/drug-label-0009-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-10-27/a73bb3b6a943796a18cd4bcd0917240b579be4636d00e6e39481bafbd8093f69/drug-label-0009-of-0014.json.zip
Source manifest SHA-256: 6be3667a3beefe6c0ead4c723ea963050533a2bc725a8044d58b07d18b258c55
Import run: 20261027T193451Z
Imported at: 2026-10-27 20:36:00

Harmonized routes table
Harmonized routes
TOPICAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 10 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
application number		M015	openfda.application_number
brand name		MAXOCAINE Topical Anesthetic Anorectal	openfda.brand_name
generic name		LIDOCAINE	openfda.generic_name
manufacturer name		PRIME COMMERCE, LLC	openfda.manufacturer_name
ndc	package	72188-076-59	openfda.package_ndc
ndc	product	72188-076	openfda.product_ndc
ndc11	package	72188007659	derived:openfda.package_ndc
spl id		361dcf5a-5697-6935-e063-6294a90aaee1	id
spl set id		26e8c867-8cb8-4a25-91b1-da45a1edd09a	set_id
unii		98PI200987	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warnings: For external use only Avoid contact with eyes. Do not exceed recommended daily dosage unless directed by physician. Stop use and consult physician if rectal bleeding occurs, if allergic reaction develops, if condition worsens or does not improve within seven days. Keep out of reach of children. If swallowed, consult physician.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.